PET imaging in anal canal cancer: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Radiology

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1259/bjr.20170370PMID 28972796PMCID PMC6047643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis

  2015cited by this paper
• Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival

  2015cited by this paper
• Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles

  2014cited by this paper
• Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

  2014cited by this paper
• Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

  2014cited by this paper
• Diagnostic Performance of Positron Emission Tomography/Computed Tomography Using Fluorine-18 Fluorodeoxyglucose in Detecting Locoregional Nodal Involvement in Patients with Anal Canal Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.

  2013cited by this paper
• Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2013cited by this paper
• Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

  2012cited by this paper
• MRI and CT of anal carcinoma: a pictorial review

  2012cited by this paper
• Role of positron emission tomography-computed tomography in the management of anal cancer.

  2012cited by this paper
• Positron emission tomography/computed tomography in the staging and treatment of anal cancer.

  2012cited by this paper
• To PET or not to PET? That is the question. Staging in anal cancer.

  2012cited by this paper
• PET/CT in anal cancer - is it worth doing?

  2012cited by this paper
• Imaging of anal carcinoma.

  2012cited by this paper
• The role of 18fluoro‐deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

  2011cited by this paper
• FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy

  2011cited by this paper
• A Comparison of CT and MRI Imaging for the Staging of Cancer of the Anal Canal

  2011cited by this paper
• Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma

  2011cited by this paper
• NCCN clinical practice guidelines in oncology. Anal carcinoma.

  2010cited by this paper
• Anal carcinoma: Clinical practice guidelines in oncology™

  2010cited by this paper
• Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.

  2010cited by this paper
• Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.

  2010cited by this paper
• FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma

  2010cited by this paper
• Anal cancers among HIV-infected persons: HAART is not slowing rising incidence

  2010cited by this paper
• The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer

  2009cited by this paper
• Outcomes and Prognostic Factors for Squamous-Cell Carcinoma of the Anal Canal: Analysis of Patients From the National Cancer Data Base

  2009cited by this paper
• FDG-PET/CT: new horizons in anal cancer.

  2009cited by this paper
• Squamous cell carcinoma of the anal canal.

  2009cited by this paper
• Can the Radiation Dose to CT-Enlarged but FDG-PET-Negative Inguinal Lymph Nodes in Anal Cancer Be Reduced?

  2009cited by this paper
• Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

  2008cited by this paper
• Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort Study

  2008cited by this paper
• Assessing the impact of FDG-PET in the management of anal cancer.

  2008cited by this paper
• Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.

  2008cited by this paper
• FDG-PET/CT in the evaluation of anal carcinoma.

  2006cited by this paper
• Positron Emission Tomography for Pretreatment Staging and Posttreatment Evaluation in Cancer of the Anal Canal

  2005cited by this paper
• A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy.

  2005cited by this paper
• Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.

  2004cited by this paper
• Exploring sources of heterogeneity in systematic reviews of diagnostic tests

  2002cited by this paper
• Malignant tumors of the anal canal

  1999cited by this paper
• Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

  1997cited by this paper
• Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

  1996cited by this paper
• Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.

  1993cited by this paper

• Diagnostic and Therapeutic Impact of FDG‐PET/CT Following MRI Staging in Anal Cancer: A Systematic Review and Meta‐Analysis

  2026influential citation
• ACR Appropriateness Criteria® Staging and Follow-up of Anal Cancer.

  2025cites this paper
• Imaging Features of Anal Carcinoma after Chemoradiation.

  2025cites this paper
• Optimising chemoradiotherapy in anal cancer

  2025cites this paper
• Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study.

  2025cites this paper
• Clinical evaluation of atlas-based auto-segmentation for contouring pelvic CTVs in the treatment of anal cancer with FDG-PET-positive lymph node involvement

  2025cites this paper
• Cancer anal : épidémiologie, histologie, clinique, exploration

  2025cites this paper
• Comparison between pelvic MRI, CT, and PET/CT in baseline staging and radiation planning of anal squamous cell carcinoma

  2024influential citation
• Tomographie par émission de positons en cancérologie digestive

  2024cites this paper
• Interstitial HDR brachytherapy for anal cancer—results and quality of life

  2024cites this paper
• Investigation of the distribution of inguinal lymph nodes and delineation of the inguinal clinical target volume using 18F-FDG PET/CT

  2024cites this paper
• A Population‐Level Validation of the New 9th Edition of the American Joint Commission on Cancer Staging System for Anal Squamous Cell Carcinoma

  2024cites this paper
• Diagnosis of Anal Cancer: Symptoms, Imaging, and Endoscopy.

  2024cites this paper
• Prognostic Value of 18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE

  2024cites this paper
• The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers—Review of the Literature

  2023influential citation
• Prognostic impact of post-treatment FDG PET/CT in anal canal cancer: a prospective study.

  2023cites this paper
• An Updated Review on Imaging and Staging of Anal Cancer—Not Just Rectal Cancer

  2023cites this paper
• [18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis

  2023cites this paper
• Pre‐ and post‐treatment FDG PET‐CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta‐analysis

  2023cites this paper
• Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

  2023cites this paper
• Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer

  2023cites this paper
• Follow-up imaging of anal cancer after treatment

  2023cites this paper
• Brazilian Society of Surgical Oncology: Guidelines for the management of anal canal cancer

  2023cites this paper
• Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology

  2023cites this paper
• Anal Cancer: The Past, Present and Future

  2023cites this paper
• Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma

  2023influential citation
• Anorectal pathology in the HIV population: a guide for radiologists

  2022cites this paper
• Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy

  2022cites this paper
• The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review

  2022influential citation
• Advances in the treatment of anal squamous cell cancer

  2022cites this paper
• Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors

  2022cites this paper
• Intensity-Modulated Radiotherapy Associated With Improved Survival Outcome in Anal Cancer

  2022cites this paper
• A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer

  2022cites this paper
• Value of PET imaging for radiation therapy

  2021cites this paper
• Anal Cancer-Diagnosis, Treatment and Follow-up.

  2021cites this paper
• Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes

  2021cites this paper
• Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.

  2021cites this paper
• S3-Leitlinie Analkarzinom

  2021cites this paper
• Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2021cites this paper
• FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience

  2021cites this paper
• Assessment of Apparent Diffusion Coefficients and SUVs as Predicators of Histological Differentiation in Anal Squamous Cell Carcinoma

  2021cites this paper
• Value of PET imaging for radiation therapy

  2021cites this paper
• Practice of radiation therapy for anal cancer in Austria—a survey on behalf of the Austrian radiation oncology society gastrointestinal tumor group (ÖGRO-GIT)

  2021cites this paper
• Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer.

  2021cites this paper
• Anal Cancer

  2021cites this paper
• Imagerie des cancers du canal anal

  2021cites this paper
• T-Staging and Target Volume Definition by Imaging in GI Tumors

  2020cites this paper
• The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal Tumors.

  2020cites this paper
• Evidence-Based PET for Abdominal and Pelvic Tumours

  2020cites this paper
• Additional Value of 2-[18F]FDG PET/CT Comparing to MRI in Treatment Approach of Anal Cancer Patients

  2020cites this paper
• PET/CT in der Strahlentherapie

  2020cites this paper
• From Image Enhancement to Imaging Biomarkers

  2020cites this paper
• Treatment outcome after radiochemotherapy in anal cancer patients staged with 18F-FDG-PET-CT

  2020cites this paper
• Improved survival in patients with FDG-PET/CT-based radiotherapy treatment planning for squamous cell anal cancer.

  2020cites this paper
• Evidence-based Positron Emission Tomography: Summary of Recent Meta-analyses on PET

  2020cites this paper
• Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer

  2020cites this paper
• Cancer de l’anus : diagnostic, bilan initial et stadification

  2020cites this paper
• Diagnostic performance and prognostic role of FDG PET/CT performed at staging in anal cancer

  2020cites this paper
• Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer

  2019cites this paper
• FEP Medical Policy Manual FEP 6.01.26 Oncologic Applications of Positron Emission Tomography Scanning

  2019cites this paper
• ARS Appropriate Use Criteria ANAL CANCER EXPERT PANEL ON ANAL CANCER:

  2019cites this paper
• Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT

  2019cites this paper
• Staging and Initial Evaluation of Anal Cancer

  2019cites this paper
• Executive Summary of the ARS Appropriate Use Criteria for Treatment of Anal Cancer.

  2019cites this paper
• Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies – effect on staging outcomes and diagnostic confidence

  2019cites this paper
• MR staging of anal cancer: what the radiologist needs to know

  2019cites this paper
• Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.

  2019cites this paper
• Ischiorectal fossa: benign and malignant neoplasms of this “ignored” radiological anatomical space

  2019cites this paper
• PET imaging in adaptive radiotherapy of gastrointestinal tumors.

  2018cites this paper
• Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients

  2018cites this paper
• Anal Cancer

  2018influential citation
• Analyse des sites de récidives après chimioradiothérapie en modulation d’intensité pour le cancer du canal anal

  2018cites this paper
• Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis

  2018cites this paper
• Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?

  2018cites this paper
• Molecular Imaging Using PET/CT for Radiation Therapy Planning for Adult Cancers: Current Status and Expanding Applications.

  2018cites this paper
• Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy

  2018cites this paper
• Anal Carcinoma , Version 2 . 2018 Clinical Practice Guidelines in Oncology

  2018cites this paper
• Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• FEP Medical Policy Manual

  2016cites this paper
• World Journal of Experimental Medicine

  year unknowncites this paper